A combination of EGF and IGF-I accelerates the progression of meiosis in bovine follicular oocytes in vitro and fetal calf serum neutralizes the acceleration effect.
The effects of a combination of EGF and IGF-I (GFs) on the progress of meiosis and on their developmental competence were examined in cumulus-enclosed bovine oocytes. Exposure to GFs in serum-free, 0.3% PVP-containing maturation medium significantly (P<0.05) increased the frequency of oocytes with the first polar body (PB) at 16 h of culture and decreased those with PB at 20 h. The cleavage rates of PB-extruded oocytes after fertilization were not affected by treatment of GFs during maturation culture, and blastocyst yield was not improved by GFs treatment. Although replacement of PVP from GFs-containing medium with fatty acid-free BSA did not affect the timing of PB extrusion, replacement with 10% FCS neutralized the acceleration effects of GFs. Replacement for macromolecule in maturation medium did not improve blastocyst yield of PB-extruded oocytes after fertilization. These results indicate that the progression of meiosis in bovine oocytes with cumulus cells is accelerated by exposure to GFs in serum-free maturation medium but their developmental competence is not improved, and that the acceleration effects on the progress of meiosis is neutralized by the presence of FCS in maturation medium with no improvement of developmental competence after in vitro fertilization.
Sakaguchi
M
M
Laboratory of Animal Reproduction, Tohoku National Agricultural Experiment Station, Morioka, Iwate, Japan. saka99@cryo.affrc.go.jp
Dominko
T
T
Leibfried-Rutledge
M L
ML
Nagai
T
T
First
N L
NL
D000818:Animals; D002417:Cattle / Q000502:physiology*; D004396:Coloring Agents / Q000737:chemistry; D004815:Epidermal Growth Factor / Q000502:physiology*; D005260:Female; D005307:Fertilization in Vitro / Q000662:veterinary; D005312:Fetal Blood / Q000502:physiology; D007334:Insulin-Like Growth Factor I / Q000502:physiology*; D008297:Male; D008540:Meiosis / Q000502:physiology*; D009865:Oocytes / Q000166:cytology* / Q000254:growth & development / Q000502:physiology; D010078:Oxazines / Q000737:chemistry; D015053:Zygote / Q000502:physiology
D004396:Coloring Agents; D010078:Oxazines; C018437:aceto-orcein; D004815:Epidermal Growth Factor; D007334:Insulin-Like Growth Factor I